Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,746 | 235 | 100.0% |
| Education | $1.05 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $412.98 | 42 | $0 (2024) |
| PFIZER INC. | $305.18 | 39 | $0 (2024) |
| Lilly USA, LLC | $280.21 | 28 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $235.95 | 14 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $166.96 | 14 | $0 (2024) |
| GlaxoSmithKline, LLC. | $165.77 | 21 | $0 (2017) |
| Amgen Inc. | $121.71 | 8 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $112.67 | 15 | $0 (2017) |
| Abbott Laboratories | $98.45 | 5 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $93.66 | 6 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $734.63 | 49 | PFIZER INC. ($142.05) |
| 2023 | $306.17 | 16 | NESTLE HEALTHCARE NUTRITION INC. ($63.91) |
| 2022 | $134.78 | 9 | Novo Nordisk Inc ($45.08) |
| 2021 | $47.77 | 3 | Novo Nordisk Inc ($34.44) |
| 2020 | $17.40 | 1 | Genentech USA, Inc. ($17.40) |
| 2019 | $31.65 | 2 | Novo Nordisk Inc ($19.26) |
| 2018 | $58.40 | 4 | Novo Nordisk Inc ($43.24) |
| 2017 | $1,417 | 152 | AstraZeneca Pharmaceuticals LP ($222.80) |
All Payment Transactions
236 individual payment records from CMS Open Payments — Page 5 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $10.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/07/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $9.06 | General |
| Category: Diabetes | ||||||
| 11/06/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $7.77 | General |
| Category: RESPIRATORY | ||||||
| 11/03/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $6.86 | General |
| Category: Diabetes | ||||||
| 11/01/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $10.12 | General |
| Category: RESPIRATORY | ||||||
| 10/30/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $6.25 | General |
| Category: DIABETES | ||||||
| 10/27/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $8.19 | General |
| Category: Diabetes | ||||||
| 10/25/2017 | Merck Sharp & Dohme Corporation | ZOSTAVAX (Biological), PNEUMOVAX 23, GARDASIL9 | Food and Beverage | In-kind items and services | $5.47 | General |
| Category: VACCINE | ||||||
| 10/20/2017 | PFIZER INC. | VIAGRA (Drug), LYRICA, EUCRISA | Food and Beverage | In-kind items and services | $9.71 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);CARDIOVASCULAR;RESPIRATORY | ||||||
| 10/18/2017 | Novo Nordisk Inc | Victoza (Drug), Xultophy 100/3.6, Tresiba | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Diabetes | ||||||
| 10/18/2017 | Ironwood Pharmaceuticals, Inc | LINZESS (Drug), VIBERZI, DUZALLO | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: Gastroenterology | ||||||
| 10/12/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $4.89 | General |
| Category: RESPIRATORY | ||||||
| 10/11/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $3.88 | General |
| Category: Diabetes | ||||||
| 10/09/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $9.22 | General |
| Category: RESPIRATORY | ||||||
| 10/06/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ZOSTAVAX | Food and Beverage | In-kind items and services | $9.52 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/02/2017 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: Respiratory | ||||||
| 09/29/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $3.94 | General |
| Category: Diabetes | ||||||
| 09/28/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $6.15 | General |
| Category: Diabetes | ||||||
| 09/27/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $10.07 | General |
| Category: RESPIRATORY | ||||||
| 09/25/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Endocrinology | ||||||
| 09/22/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: DIABETES | ||||||
| 09/20/2017 | Merck Sharp & Dohme Corporation | NUVARING (Drug), NEXPLANON | Food and Beverage | In-kind items and services | $7.68 | General |
| Category: WOMENS HEALTH | ||||||
| 09/18/2017 | PFIZER INC. | VIAGRA (Drug), TOVIAZ, LYRICA | Food and Beverage | In-kind items and services | $8.08 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);CARDIOVASCULAR;RESPIRATORY | ||||||
| 09/13/2017 | Novo Nordisk Inc | Victoza (Drug), Xultophy 100/3.6, Tresiba | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Diabetes | ||||||
| 09/13/2017 | Novo Nordisk Inc | Victoza (Drug), Xultophy 100/3.6, Tresiba | Food and Beverage | In-kind items and services | $0.38 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 884 | 1,345 | $154,635 | $56,996 |
| 2022 | 11 | 667 | 1,084 | $129,673 | $44,805 |
| 2021 | 13 | 691 | 1,131 | $119,032 | $44,908 |
| 2020 | 17 | 774 | 1,153 | $117,102 | $38,834 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 222 | 461 | $110,640 | $34,075 | 30.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 37 | 37 | $8,362 | $4,522 | 54.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 15 | 17 | $7,650 | $3,543 | 46.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 40 | 40 | $3,480 | $2,877 | 82.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 175 | 337 | $3,370 | $2,766 | 82.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 46 | $7,360 | $2,461 | 33.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 115 | 115 | $2,875 | $2,000 | 69.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 45 | 45 | $2,250 | $1,277 | 56.8% |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | Office | 2023 | 20 | 21 | $1,470 | $1,056 | 71.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 49 | 78 | $2,340 | $716.20 | 30.6% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 36 | 36 | $792.00 | $626.04 | 79.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 16 | 31 | $1,116 | $502.82 | 45.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 27 | 28 | $1,680 | $268.25 | 16.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 12 | 12 | $840.00 | $218.00 | 26.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 33 | 41 | $410.00 | $88.00 | 21.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 180 | 408 | $97,920 | $30,470 | 31.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 20 | 22 | $9,900 | $4,584 | 46.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 47 | 47 | $4,089 | $3,221 | 78.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 32 | 37 | $5,920 | $2,044 | 34.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 54 | 55 | $2,750 | $1,502 | 54.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 163 | 308 | $3,080 | $883.67 | 28.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 50 | 50 | $1,250 | $827.42 | 66.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 42 | 71 | $2,130 | $646.56 | 30.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 31 | 32 | $1,920 | $295.88 | 15.4% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 14 | 14 | $314.00 | $247.20 | 78.7% |
About Dr. April Brinkhoff, MD
Dr. April Brinkhoff, MD is a Family Medicine healthcare provider based in Lincoln, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861406365.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. April Brinkhoff, MD has received a total of $2,747 in payments from pharmaceutical and medical device companies, with $734.63 received in 2024. These payments were reported across 236 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($2,746).
As a Medicare-enrolled provider, Brinkhoff has provided services to 3,016 Medicare beneficiaries, totaling 4,713 services with total Medicare billing of $185,542. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Lincoln, NE
- Active Since 07/28/2006
- Last Updated 04/18/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1861406365
Products in Payments
- JARDIANCE (Drug) $188.79
- Victoza (Drug) $142.21
- Prolia (Biological) $121.71
- Wegovy (Drug) $106.68
- Ozempic (Drug) $101.27
- COMIRNATY (Biological) $90.38
- SYMBICORT (Drug) $89.32
- SOLIQUA (Drug) $88.99
- TRADJENTA (Drug) $80.24
- Veozah (Drug) $75.82
- ANORO (Drug) $70.39
- TRULICITY (Drug) $68.06
- FARXIGA (Drug) $66.73
- FREESTYLE LIBRE 3 (Device) $64.16
- VIAGRA (Drug) $63.99
- ZENPEP (Drug) $63.91
- Rybelsus (Drug) $62.23
- BREO (Drug) $61.72
- XIFAXAN (Drug) $57.29
- TAGRISSO (Drug) $52.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lincoln
Michael Israel, Md, MD
Family Medicine — Payments: $349,300
Dr. Randy Kohl, Md, MD
Family Medicine — Payments: $62,594
Matthew Glenn, Md, MD
Family Medicine — Payments: $20,293
Mr. Charles Kreshel, M.d, M.D
Family Medicine — Payments: $15,102
Gary Van Ert, Md, MD
Family Medicine — Payments: $12,981
Uma Nooka, Md, MD
Family Medicine — Payments: $12,976